[1] Li Y Z, Teng D, Shi X G, et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. British Medical Journal, 2020, 369: m997. doi: 10.1136/bmj.m997. [2] Calvo-Maroto A M, Esteve-Taboada J J, Pérez-Cambrodí RJ, et al. Pilot study on visual function and fundus autofluorescence assessment in diabetic patients[J]. Journal of Ophthalmology, 2016, 2016: 1287847. doi:10.1155/2016/1287847. [3] 许咏梅, 施云峰. 中国红茶出口“一带一路”沿线国家贸易及其影响因素实证分析[J]. 茶叶科学, 2019, 39(5): 602-610. Xu Y M, Shi Y F.An empirical analysis of the trade and influencing factors of China's black tea export to countries along the Belt and Road[J]. Journal of Tea Science, 2019, 39(5): 602-610. [4] 王洪新, 孙军涛, 吕文平, 等. 茶黄素的制备、分析、分离及功能活性研究进展[J]. 食品与生物技术学报, 2011, 30(1): 12-19. Wang H X, Sun J T, Lv W P, et al.Research progress on preparation, analysis, separation and funtion of theaflavins[J]. Journal of Food Science and Biotechnology, 2011, 30(1): 12-19. [5] He H F.Research progress on theaflavins: efficacy, formation, and preparation[J]. Food & Nutrition Research, 2017, 61(1): 1344521. doi: 10.1080/16546628.2017.1344521. [6] Lin Y L, Tsai S H, Lin-Shiau S Y, et al. Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-кB in macrophages[J]. European Journal of Pharmacology, 1999, 367(2/3): 379-388. [7] 雷时成, 孙大利, 王亚洁, 等. 茶黄素双没食子酸酯的生物活性及其作用机制[J]. 食品与机械, 2020, 36(2): 229-236. Lei S C, Sun D L, Wang Y J, et al.Biological activities of theaflavin-3,3'-digallate and its mechanism of action[J]. Food & Machinery, 2020, 36(2): 229-236. [8] Ogurtsova K, da Rocha Fernandes J D, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040[J]. Diabetes Research and Clinical Practice, 2017, 128: 40-50. [9] Simmons R K, Griffin S J, Lauritzen T, et al.Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009[J]. Diabetologia, 2017, 60(11): 2192-2199. [10] Tancredi M, Rosengren A, Svensson A M, et al.Excess mortality among persons with type 2 diabetes[J]. The New England Journal of Medicine, 2015, 373(18): 1720-1732. [11] Cull C A, Jensen C C, Retnakaran R, et al.Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom prospective diabetes study 78[J]. Circulation, 2007, 116(19): 2119-2126. [12] Zhang J, Chen J, Yang J, et al.Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-KappaB pathway[J]. Cellular Physiology & Biochemistry, 2013, 31(2/3): 230-241. [13] Ben Lagha A, Grenier D.Black tea theaflavins attenuate porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity[J]. Journal of Periodontal Research, 2017, 52(3): 458-470. [14] Tan Q, Peng L, Huang Y, et al.Structure-activity relationship analysis on antioxidant and anticancer actions of theaflavins on human colon cancer cells[J]. Journal of Agricultural and Food Chemistry, 2019, 67(1): 159-170. [15] Duewell P, Kono H, Rayner K J, et al.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J]. Nature, 2010, 464(7306): 1357-1361. [16] Jin Y, Fu J.Novel insights into the NLRP3 inflammasome in atherosclerosis[J]. Journal of the American Heart Association, 2019, 8(12): e012219. doi: 10.1161/jaha.119.012219. [17] Jin C, Flavell R A.Molecular mechanism of NLRP3 inflammasome activation[J]. Journal of Clinical Immunology, 2010, 30(5): 628-631. [18] Eisenbarth S C, Colegio O R, O'Connor W, et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants[J]. Nature, 2008, 453(7198): 1122-1126. [19] Zhao J, Wang Z, Yuan Z, et al.Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice[J]. Diabetes & Vascular Disease Research, 2020, 17(6): 1479164120977441. doi: 10.1177/1479164120977441. [20] Wang R, Wang Y, Mu N, et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J]. Laboratory Investigation, 2017, 97(8): 922-934. [21] Du R H, Tan J, Sun X Y, et al. Fluoxetine inhibits NLRP3 inflammasome activation: implication in depression [J]. International Journal of Neuropsychopharmacology, 2016, 19(9): pyw037. doi: 10.1093/ijnp/pyw037. |